Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 475 institutions that hold shares in the stock, with a total of 64.2 Million shares, which have been reported (via 13F filing form) to have a value of $3.54 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wolff Wiese Magana LLC
|
Jul 17, 2025 Q2 2025 |
100
shares
|
$5,509
0.0% of portfolio
|
Q1 2023
Reduced 21.88%
|
|
Bogart Wealth, LLC
|
May 01, 2025 Q1 2025 |
100
shares
|
$5,509
0.0% of portfolio
|
Q1 2025
New holding
|
|
Rakuten Securities, Inc.
Tokyo, M0 |
Apr 18, 2025 Q1 2025 |
95
shares
|
$5,233
0.0% of portfolio
|
Q1 2025
Reduced 20.83%
|
|
Caitong International Asset Management Co., LTD
Hong Kong, K3 |
May 13, 2025 Q1 2025 |
91
shares
|
$5,013
0.0% of portfolio
|
Q1 2025
Reduced 96.32%
|
|
Stone House Investment Management, LLC
|
May 12, 2025 Q1 2025 |
90
shares
|
$4,958
0.0% of portfolio
|
Q1 2025
New holding
|
|
Bellwether Advisors, LLC
|
May 07, 2025 Q1 2025 |
88
shares
|
$4,847
0.0% of portfolio
|
Q4 2024
New holding
|
|
Pinnacle Bancorp, Inc.
|
Jul 11, 2025 Q2 2025 |
86
shares
|
$4,737
0.0% of portfolio
|
Q1 2023
New holding
|
|
West Paces Advisors Inc.
Atlanta, GA |
Apr 14, 2025 Q1 2025 |
85
shares
|
$4,682
0.0% of portfolio
|
Q4 2021
Reduced 58.82%
|
|
Pflug Koory, LLC
|
Apr 17, 2025 Q1 2025 |
84
shares
|
$4,627
0.0% of portfolio
|
Q4 2019
New holding
|
|
Oliver Lagore Vanvalin Investment Group
Flint, MI |
Jul 10, 2025 Q2 2025 |
75
shares
|
$4,131
0.0% of portfolio
|
Q4 2024
Reduced 34.78%
|
|
Principal Securities, Inc.
Des Moines, IA |
Apr 30, 2025 Q1 2025 |
71
shares
|
$3,911
0.0% of portfolio
|
Q4 2024
Reduced 89.03%
|
|
Dogwood Wealth Management LLC
Lenexa, KS |
Jul 18, 2025 Q2 2025 |
70
shares
|
$3,856
0.0% of portfolio
|
Q4 2024
New holding
|
|
Gould Capital, LLC
|
May 14, 2025 Q1 2025 |
70
shares
|
$3,856
0.0% of portfolio
|
Q4 2024
Reduced 33.33%
|
|
Greykasell Wealth Strategies, Inc.
Danville, CA |
May 09, 2025 Q1 2025 |
68
shares
|
$3,746
0.0% of portfolio
|
Q1 2025
New holding
|
|
Quadrant Capital Group LLC
Cincinnati, OH |
May 13, 2025 Q1 2025 |
67
shares
|
$3,691
0.0% of portfolio
|
Q1 2025
Reduced 29.47%
|
|
Ogorek Anthony Joseph
|
May 09, 2025 Q1 2025 |
65
shares
|
$3,580
0.0% of portfolio
|
Q4 2024
New holding
|
|
Main Street Group, LTD
Glen Allen, VA |
Jul 15, 2025 Q2 2025 |
62
shares
|
$3,415
0.0% of portfolio
|
Q4 2024
Reduced 88.73%
|
|
Baystate Wealth Management LLC
|
Jan 29, 2024 Q4 2023 |
61
shares
|
$3,360
0.0% of portfolio
|
Q2 2023
New holding
|
|
Rothschild Investment LLC
Chicago, IL |
Apr 08, 2025 Q1 2025 |
60
shares
|
$3,305
0.0% of portfolio
|
Q1 2024
Reduced 33.33%
|
|
Russell Investments Group, Ltd.
|
May 13, 2025 Q1 2025 |
60
shares
|
$3,305
0.0% of portfolio
|
Q1 2025
Added 20.0%
|
|
Ifs Advisors, LLC
|
Apr 10, 2025 Q1 2025 |
59
shares
|
$3,250
0.0% of portfolio
|
Q1 2025
New holding
|
|
Skopos Labs, Inc.
Riverhead, NY |
May 13, 2025 Q1 2025 |
59
shares
|
$3,250
0.0% of portfolio
|
Q1 2025
New holding
|
|
Birchbrook, Inc.
Bangor, ME |
Jun 10, 2025 Q1 2025 |
50
shares
|
$2,754
0.0% of portfolio
|
Q4 2023
New holding
|
|
Community Bank, N.A.
|
Apr 21, 2025 Q1 2025 |
50
shares
|
$2,754
0.0% of portfolio
|
Q1 2024
New holding
|
|
Capital Analysts, LLC
Fort Washington, PA |
May 14, 2025 Q1 2025 |
49
shares
|
$2,699
0.0% of portfolio
|
Q1 2024
New holding
|